Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy LivaNova stock (LIVN)

Buy LivaNova stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

LivaNova is a medical devices business based in the US. LivaNova shares (LIVN) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $52.10 – an increase of 0.56% over the previous week. LivaNova employs 2,900 staff and has a trailing 12-month revenue of around $1.2 billion.

Our top picks for where to buy LivaNova stock

Our pick for investing by theme

Go to site
  • Trade $0 commission stocks & ETFs with as little as $1
  • Earn up to $300 with qualifying deposits
  • Discover new opportunities with Opto's AI-driven thematic investing system
  • Theme and ETF screener

Our pick for transfer bonus

Go to site
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options with no options contract fees
  • Complimentary access to a financial planner

Top pick for advanced traders

Go to site
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

How to buy LivaNova stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – LIVN. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy LivaNova stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
Name Product USFST Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
OPTO
Finder Score: 3.1 / 5: ★★★★★
OPTO
★★★★★
Stocks, ETFs
$0
$0
N/A
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
SoFi Invest®
Finder Score: 4.1 / 5: ★★★★★
SoFi Invest®
★★★★★
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $1,000 in stock
Zero-commission stocks, ETFs and options, with no options per-contract fees. Plus, a complimentary access to financial planners.
Tastytrade
Finder Score: 4.4 / 5: ★★★★★
Tastytrade
★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
Robinhood
Finder Score: 4.5 / 5: ★★★★★
Robinhood
★★★★★
Stocks, Options, ETFs, Cryptocurrency
$0
$0
4.5%
Get a free stock
Trade stocks, options, ETFs and crypto without commissions and on a user-friendly platform. Plus, a 1% IRA match and no options contract fees.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

LivaNova stock price (NASDAQ: LIVN)

Use our graph to track the performance of LIVN stocks over time.

LivaNova shares at a glance

Information last updated 2024-11-15.
Latest market close$52.10
52-week range$42.75 - $64.48
50-day moving average $51.56
200-day moving average $53.03
Wall St. target price$69.00
PE ratio 121.6744
Dividend yield N/A
Earnings per share (TTM) $0.43

Is it a good time to buy LivaNova stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

LivaNova price performance over time

Historical closes compared with the close of $52.1 from 2024-11-15

1 week (2024-11-12) -1.70%
1 month (2024-10-18) -2.74%
3 months (2024-08-19) 13.31%
6 months (2024-05-17) -15.91%
1 year (2023-11-17) 11.40%
2 years (2022-11-18) -1.77%
3 years (2021-11-19) 86.07
5 years (2019-11-19) 79.21

Is LivaNova stock undervalued or overvalued?

Valuing LivaNova stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of LivaNova's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

LivaNova's P/E ratio

LivaNova's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 122x. In other words, LivaNova shares trade at around 122x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

LivaNova's PEG ratio

LivaNova's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.4953. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into LivaNova's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

LivaNova's EBITDA

LivaNova's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $212.6 million.

The EBITDA is a measure of a LivaNova's overall financial performance and is widely used to measure a its profitability.

LivaNova financials

Revenue TTM $1.2 billion
Operating margin TTM 14.09%
Gross profit TTM $696.7 million
Return on assets TTM 4.34%
Return on equity TTM 1.87%
Profit margin 1.91%
Book value $24.13
Market Capitalization $2.8 billion

TTM: trailing 12 months

LivaNova share dividends

We're not expecting LivaNova to pay a dividend over the next 12 months.

LivaNova share price volatility

Over the last 12 months, LivaNova's shares have ranged in value from as little as $42.75 up to $64.475. A popular way to gauge a stock's volatility is its "beta".

LIVN.US volatility(beta: 1.01)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while LivaNova's is 1.009. This would suggest that LivaNova's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

LivaNova overview

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors.

Frequently asked questions

What percentage of LivaNova is owned by insiders or institutions?
Currently 0.33% of LivaNova shares are held by insiders and 101.548% by institutions.
How many people work for LivaNova?
Latest data suggests 2,900 work at LivaNova.
When does the fiscal year end for LivaNova?
LivaNova's fiscal year ends in December.
Where is LivaNova based?
LivaNova's address is: 20 Eastbourne Terrace, London, United Kingdom, W2 6LG
What is LivaNova's ISIN number?
LivaNova's international securities identification number is: GB00BYMT0J19
What is LivaNova's CUSIP number?
LivaNova's Committee on Uniform Securities Identification Procedures number is: G5509L101

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site